Maybe we get some good news and nice surprises more regularly over the coming months. Seems the company is flagging PW will stand down at some point. I imagine he needs a change, new challenge or a rest. Hope it a gradual process and perhaps a seat on the board? End of quarter sales will hopefully show some significant USA sales and revenue as the next catalyst. Once the phase 2 XP trial commences, it will give some more safety data in a new sensitive cohort. Also looking forward to the penumbra targets. Perhaps a couple of months away? They have been flagging some inorganic growth for some time now so I imagine they know what they are after and will take an opportunity should it arise. I don’t see any negatives but then that’s half glass full for you!! GLTA
CUV Price at posting:
$23.60 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)